| 1 |
Manufacturing and marketing of unapproved drug product Sodium Hyaluronate Eye Drops 0.3% w/v |
2026-Mar-18 |
|
351 KB |
| 2 |
Guidance document on dossier based licensing of Drugs for uniform product licensing in the country |
2026-Mar-17 |
|
822 KB |
| 3 |
Addendum to FAQ on Medical Devices Rules, 2017 |
2026-Mar-13 |
|
321kb |
| 4 |
Transfer of certain functions and delegation of powers to the zonal offices of CDSCO under Rule 22 of the Drugs and Cosmetics Rules, 1945 |
2026-Mar-13 |
|
271 KB |
| 5 |
Cancellation of products under RC/COS-005358, for import of Cosmetics under Cosmetics Rules, 2020 (M/s. Beauty Garage India Pvt ltd) |
2026-Mar-12 |
|
514 KB |
| 6 |
Advisory to all manufacturers, importers and marketing authorization holders |
2026-Mar-11 |
|
574 KB |
| 7 |
Testing Laboratories approved by Statas&UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 |
2026-Mar-10 |
|
418 KB |
| 8 |
Alert on theft of Lantus® SoloStar® (Insulin Glargine Injection IP, râDNA origin, 100 IU/mL Batch No. 5F0347B of M/s Sanofi India Limited during transit |
2026-Mar-03 |
|
69 KB |
| 9 |
Cancellation of Registration Certificates and lmport Registration Numbers for lmport of Cosmetics under the Cosmetics Rules, 2020- Regarding |
2026-Feb-23 |
|
1314 KB |
| 10 |
Carbimazole related agranulocytosis - Recommendations for the change in Prescribing Information Leaflets (PILs) |
2026-Feb-17 |
|
518 KB |
